NCT03238482View on ClinicalTrials.gov

Comparing Salmeterol/Fluticasone Easyhaler and Seretide Diskus (SAIMI)

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

August 16, 2017

Primary Completion Date

December 19, 2017

Study Completion Date

December 19, 2017

Conditions
Asthma
Interventions
DRUG

salmeterol-fluticasone

Seretide Diskus 50/250 µg/dose

DRUG

salmeterol-fluticasone

Salmeterol/fluticasone Easyhaler 50/250 µg/dose, product E

DRUG

salmeterol-fluticasone

Salmeterol/fluticasone Easyhaler 50/250 µg/dose, product F

DRUG

salmeterol-fluticasone

Salmeterol/fluticasone Easyhaler 50/250 µg/dose, product G

Trial Locations (1)

Unknown

Clinical Pharmacology Unit, Orion Pharma, Espoo

All Listed Sponsors
lead

Orion Corporation, Orion Pharma

INDUSTRY

NCT03238482 - Comparing Salmeterol/Fluticasone Easyhaler and Seretide Diskus (SAIMI) | Biotech Hunter | Biotech Hunter